ATR04-484

· Azitra Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATR04-484, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity [Phase 1, Phase 2]